OncoScint CR/OV monoclonal-based imaging agent targeting the TAG-72 glycoprotein expressed by colon and breast cancer cell lines: Began multicenter Phase II tri

Cytogen Corp. (CYTO), Princeton, N.J. Product: OncoScint CR/OV monoclonal-based imaging agent targeting the TAG-72 glycoprotein expressed by colon and breast cancer cell lines Use: Detect lymph node ...